Pharvaris N.V. (PHVS)

Pharvaris Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	368.34	391.23	161.84	209.35	98.63	20.33
Cash & Cash Equivalents	368.34	391.23	161.84	209.35	98.63	20.33
Cash Growth	172.48%	141.74%	-22.70%	112.26%	385.23%	277.44%
Receivables	0.36	0.42	0.38	0.7	0.57	0.21
Other Current Assets	7.59	5.58	4.63	1.51	1.75	0.05
Total Current Assets	376.3	397.24	166.85	211.57	100.95	20.58
Property, Plant & Equipment	0.42	0.46	0.63	0.35	0.05	0.01
Other Long-Term Assets	0.88	1	0.26	0.17	0.1	0
Total Long-Term Assets	1.3	1.46	0.89	0.52	0.15	0.01
Total Assets	377.6	398.69	167.73	212.09	101.1	20.6
Accounts Payable	5.56	2.91	6.69	2.49	0.83	0.52
Current Debt	0.12	0.2	0.19	0.1	0	0
Other Current Liabilities	-	-	-	-	4.48	1.41
Total Current Liabilities	-	-	-	-	5.31	1.92
Long-Term Debt	0.07	0.04	0.25	0.15	0	0
Total Liabilities	18.43	14.65	18.47	7.14	5.31	1.92
Total Debt	0.19	0.24	0.44	0.25	0	0
Debt Growth	-50.72%	-45.31%	74.60%	-	-	-
Retained Earnings	-294.02	-265.92	-164.19	-87.57	-44.46	-18.47
Comprehensive Income	0.02	-0.01	0.04	0.03	-0	0
Shareholders' Equity	359.17	384.05	149.26	204.95	95.79	18.67
Net Cash / Debt	368.15	390.99	161.4	209.1	98.63	20.33
Net Cash / Debt Growth	173.12%	142.25%	-22.81%	112.01%	385.23%	277.44%
Working Capital	-	-	-	-	95.64	18.66
Book Value Per Share	8.76	9.37	4.42	6.19	3.14	0.61

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).